Eupalinolide O Induces Apoptosis in Human Triple‐Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway
Y Zhao, L Fu, J Chen, J Zhou, C Tian… - Journal of …, 2022 - Wiley Online Library
Background. Triple‐negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway.
Y Zhao, L Fu, J Chen, J Zhou, C Tian, D Zhou… - Journal of …, 2022 - europepmc.org
Background Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway
Y Zhao, L Fu, J Chen, J Zhou, C Tian… - Journal of …, 2022 - search.proquest.com
Background. Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
[HTML][HTML] Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway
Y Zhao, L Fu, J Chen, J Zhou, C Tian, D Zhou… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway.
Y Zhao, L Fu, J Chen, J Zhou, C Tian… - Journal of …, 2022 - search.ebscohost.com
Background. Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway
Y Zhao, L Fu, J Chen, J Zhou, C Tian… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
Eupalinolide O Induces Apoptosis in Human Triple-Negative Breast Cancer Cells via Modulating ROS Generation and Akt/p38 MAPK Signaling Pathway.
Y Zhao, L Fu, J Chen, J Zhou, C Tian, D Zhou… - Journal of …, 2022 - europepmc.org
Background Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …
therapeutic options. Eupalinolide O (EO) was reported to inhibit tumor growth. This study is …